XT Hi-Tech provides future category leaders with capital, advice, and support throughout their entire journey. Our track record empowers us to invest in those companies we believe will be the next category leaders – even in categories that are still under construction… We believe in true partnerships, so before joining we try to learn how we can work together all the way, through the highs and lows that are always part of the journey. When partnering, we see it as our mission to make management teams as successful as possible, supporting them with capital, a broad network of connections, operational know-how, and 24/7 advice - all based on decades of experience in taking companies from any stage to category leadership. Our venture team has a strong mix of entrepreneurial, operational, and investment expertise and we are active members of our companies’ board of directors. By implementing our strategy, we managed to be a significant ingredient in the creation of market leaders such as Phytech, Checkmarx, Enzymotec, Cymbio, Sofwave, and Lumenis. In fact, since inception, we have invested in over 80 companies, which resulted in over 30 IPOs and M&As, 15 portfolio companies, and 3 unicorns. We invite you to reach out to us via [email protected].
14
Total Investments
11
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About XT Hi-Tech
Recent Investments (14)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Early VC | •••••• | Mar 2024 | |
| Series A | •••••• | Dec 2022 | |
| Series A | •••••• | Jun 2022 | |
| Seed Round | •••••• | Apr 2022 | |
| Series B | •••••• | Nov 2021 | |
|
|
Venture Round | •••••• | Oct 2021 |
|
|
Series A | •••••• | Mar 2021 |
|
|
Seed Round | •••••• | Jan 2021 |
|
|
Seed Round | •••••• | Jun 2020 |
|
|
Series A | •••••• | Aug 2019 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.